We recently looked at Goldman Sachs’ Stocks With Highest Consensus Returns: 42 Stocks With The Highest Consensus ROE. In this ...

NBA Hall of Famer Earvin “Magic” Johnson is investing in a pharmacy startup that helps clinics with high volumes of HIV ...

An Antidiabetic Helps the Immune System Recognize Reservoirs of HIV Sep. 10, 2024 — Metformin, a drug used to treat type 2 diabetes, could help deplete the viral reservoir and eliminate it ...

Researchers looked at 198 kidney transplants performed at hospitals across the United States. They found similar results ...

The availability of such kidney transplants outside of the research setting could substantially improve organ availability ...

A new study found people with HIV can safely receive donated kidneys from deceased donors with the virus. According to ...

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...

As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources to create the next generation of healthcare treatments. The company's innovative new product lineup and ...

Moderate and high SUD risk was significantly increased among people living with HIV during the COVID-19 pandemic, between 2018 and 2022.

Gilead's partnership with generic manufacturers to lower the cost of its HIV drug lenacapavir is criticized for being too restrictive. Key countries with rising HIV rates are excluded, and the ...

Gilead Sciences has announced that cheaper versions of its “gamechanger” HIV prevention drug, lenacapavir, will be made available in 120 low and middle income countries. Lenacapavir is an ...